Monday, April 13, 2026 11:55:52 AM
I don't know but reading the news it really sounds to me like they were spiking the punchbowl right at assessment times. IMO very very unethical. The FDA is right to want another trial since the one they did was "altered" by injecting lesions kinda nullifies everything they were trying to show the DRUG does not the regular standard of care.
Recent REPL News
- Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/27/2026 12:00:00 PM
- Replimune plunges after second FDA setback for melanoma therapy; analysts turn bearish • IH Market News • 04/13/2026 10:28:58 AM
- Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma • GlobeNewswire Inc. • 04/10/2026 09:02:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 01:11:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 01:10:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 01:10:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 01:09:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 01:09:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 01:08:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 01:08:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 01:07:45 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 08:30:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/02/2026 08:15:34 PM
- Replimune to Present at Two Upcoming Investor Conferences • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 01:28:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/03/2026 01:12:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2026 01:05:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:00:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 10:11:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 10:10:07 PM
- Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/18/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2025 09:30:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/02/2025 09:11:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:31:07 PM
- Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025) • GlobeNewswire Inc. • 11/07/2025 09:45:00 PM

